Is silymarin hepatoprotective in alcoholic liver disease?

被引：8

作者：

Berger, J ^{[1
]}

Kowdley, KV ^{[1
]}

机构：

[1] Univ Washington, Med Ctr, Div Gastroenterol, Seattle, WA 98195 USA

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 2003年 / 37卷 / 04期

关键词：

D O I：

10.1097/00004836-200310000-00002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：278 / 279

页数：2

相关论文

共 15 条

[1]

Oxidants and antioxidants in alcohol-induced liver disease [J].

Arteel, GE .

GASTROENTEROLOGY, 2003, 124 (03) :778-790

[2]

BENDA L, 1980, WIEN KLIN WOCHENSCHR, V92, P678

[3]

BLUMENTHAL M, 2001, HERBALGRAM, V51

[4]

BUNOUT D, 1992, REV MED CHILE, V120, P1370

[5]

FEHER J, 1989, Orvosi Hetilap, V130, P2723

[6]

RANDOMIZED CONTROLLED TRIAL OF SILYMARIN TREATMENT IN PATIENTS WITH CIRRHOSIS OF THE LIVER [J].

FERENCI, P ;

DRAGOSICS, B ;

DITTRICH, H ;

FRANK, H ;

BENDA, L ;

LOCHS, H ;

MERYN, S ;

BASE, W ;

SCHNEIDER, B .

JOURNAL OF HEPATOLOGY, 1989, 9 (01) :105-113

[7]

Milk thistle (Silybum marianum) for the therapy of liver disease [J].

Flora, K ;

Hahn, M ;

Rosen, H ;

Benner, K .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (02) :139-143

[8]

BIOAVAILABILITY OF SILYMARIN .1. VOLUMES OF DISTRIBUTION OF SILYBIN, SILYDIANIN, AND SILYCHRISTIN FROM INVITRO DATA [J].

KOCH, HP ;

RITSCHEL, WA .

ARCHIV DER PHARMAZIE, 1981, 314 (06) :515-517

[9]

LIEBER CS, 1994, METHOD ENZYMOL, V233, P585

[10]

Mulrow C, 2000, AHRQ PUBLICATION